Figure 1).
A, B, C, D and E protocols were used for studies with tumour necrosis factor-alpha (TNF-α) perfusion (perf) and protection with ischemic preconditioning (IPC) and 17-beta estradiol (E2). Protocols F and G were used for combined protective studies with hyperthermic IPC and E2 perf and pretreatment. Rec Recirculating
